臨床試驗設備和輔助解決方案市場 - 按類型、服務、最終用戶 - 全球預測

Clinical Trial Equipment & Ancillary Solutions Market - By Type, Service, End-user - Global Forecast

出版日期: 2024年04月29日 | 出版商:

Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在加強合作夥伴關係以推動創新和擴大先進技術的取得的推動下，臨床試驗設備和輔助解決方案市場預計從 2024 年到 2032 年將實現 7.5% 的複合年成長率。各公司正在聯手整合不同的專業知識和資源，以加強遠端監控設備和專用診斷工具等試驗設備的開發和部署。這些合作也利用研究和技術的綜合優勢提高了試驗效率和患者結果。例如，2024年5月，醫療保健研究和技術公司Clario宣布與臨床試驗醫療設備的著名供應商Emsere建立策略合作夥伴關係，透過結合專業知識和資源來增強臨床試驗設備和輔助解決方案。

整個市場分為類型、服務、最終用戶和地區。

就類型而言，由於自動化樣品處理和高通量分析系統等創新不斷增加，實驗室儀器領域的臨床試驗設備和輔助解決方案市場預計在2024 年至2032 年期間將出現顯著的複合年成長率。這些儀器能夠更有效地收集和分析資料，從而提高臨床試驗的精度和可靠性。該公司還整合尖端技術，例如用於即時資料分析和預測建模的人工智慧，以最佳化實驗室工作流程並改善研究成果。

從最終用戶來看，生物技術公司領域的臨床試驗設備和輔助解決方案產業預計將在 2024 年至 2032 年期間成長，這主要得益於基因治療工具和先進診斷平台等尖端技術的廣泛採用。這些公司正在增強其研究能力，以開發個人化治療和標靶療法，以改善患者的治療結果和醫療保健功效。與學術機構和醫療保健提供者的合作也正在推動生物技術的進步，以促進更精確的臨床試驗，同時加速新型醫療解決方案的發展。

從地區來看，在慢性病增多和醫療保健進步的推動下，亞太地區臨床試驗設備和輔助解決方案市場規模預計將在 2024 年至 2032 年間呈現強勁成長。遠端監控設備和數位健康平台等技術擴大被採用來提高患者護理和研究效率。這些進步正在增強進行複雜臨床試驗和收集即時健康資料的能力，以促進該地區更好的疾病管理和治療結果。

產業生態系統分析
產業影響力
- 成長動力
  - 臨床試驗的全球化
  - 將臨床試驗外包給 CRO 的需求不斷成長
  - 政府和非政府對臨床試驗的資助增加
  - 專注於以病人為中心的試驗
  - 科技不斷進步
- 產業陷阱與挑戰
  - 複雜而嚴格的監管要求
  - 發展中國家基礎建設有限
成長潛力分析
監管環境
按地區分類的臨床試驗量
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
診斷設備
實驗室儀器
配對解決方案

第 6 章：市場估計與預測：按服務分類，2021 - 2032 年

主要趨勢
租賃及租賃服務
供應及物流服務
監理合規服務
軟體服務

第 7 章：市場估計與預測：按最終用戶分類，2021 - 2032 年

主要趨勢
製藥和生物技術公司
合約研究組織 (CRO)
醫療器材企業
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭人
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Andwin Scientific
Ancillare, LP.
AXELERIST FINANCIAL
Biocair
ICON plc
Imperial CRS, LLC.
Marken
MESM UK.
Myonex
NUVISAN
Oximio
Parexel International (MA) Corporation
Quipment SAS
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 9268

Clinical Trial Equipment and Ancillary Solutions Market is projected to accrue 7.5% CAGR from 2024 to 2032, driven by increasing partnerships for driving innovations and expanding access to advanced technologies. Companies are joining forces to integrate diverse expertise and resources for enhancing the development and deployment of trial equipment, such as remote monitoring devices and specialized diagnostic tools. These collaborations are also improving trial efficiency and patient outcomes for leveraging combined strengths in research and technology. For instance, in May 2024, Clario, a healthcare research and technology company, announced a strategic partnership with Emsere, a prominent supplier of medical equipment for clinical trials, to enhance clinical trial equipment and ancillary solutions through combined expertise and resources.

The overall market is segregated into type, service, end-user, and region.

In terms of type, the clinical trial equipment and ancillary solutions market from the laboratory instruments segment is expected to witness significant CAGR from 2024 to 2032 due to the increasing innovations, such as automated sample processing and high-throughput analysis systems. These instruments are enabling more efficient data collection and analysis for enhancing the precision and reliability of clinical trials. Companies are also integrating cutting-edge technologies, such as AI for real-time data analysis and predictive modeling to optimize laboratory workflows and improve research outcomes.

By End-User, the clinical trial equipment and ancillary solutions industry from the biotechnology companies segment is projected to rise from 2024 to 2032 led by higher adoption of cutting-edge technologies, such as gene therapy tools and advanced diagnostic platforms. These companies are enhancing their research capabilities to develop personalized treatments and targeted therapies to improve patient outcomes and healthcare efficacy. Collaborations with academic institutions and healthcare providers are also driving advancements in biotechnology for facilitating more precise clinical trials while accelerating the development of novel medical solutions.

Regionally, the Asia Pacific clinical trial equipment and ancillary solutions market size is projected to exhibit robust growth between 2024 and 2032, fueled by the rising chronic diseases and advancements in healthcare. Technologies, such as remote monitoring devices and digital health platforms are increasingly adopted to improve patient care and research efficacy. These advancements are enhancing the capability to conduct complex clinical trials and gathering real-time health data for facilitating better disease management and treatment outcomes in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Globalization of clinical trials
  - 3.2.1.2 Growing demand for outsourcing clinical trials to CROs
  - 3.2.1.3 Rise in government and non-government funding for clinical trials
  - 3.2.1.4 Focus on patient-centric trials
  - 3.2.1.5 Growing technology advancements
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Complex and stringent regulatory requirements
  - 3.2.2.2 Limited infrastructure in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Clinical trial volume, by region
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Diagnostic equipment
5.3 Laboratory instruments
5.4 Ancillary solutions

Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Rental & leasing services
6.3 Supply and logistics services
6.4 Regulatory compliance services
6.5 Software services

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 Contract research organizations (CROs)
7.4 Medical device companies
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 The Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa